StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

Investment analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a report issued on Saturday. The brokerage set a “hold” rating on the stock.

Separately, Benchmark started coverage on Milestone Scientific in a research report on Thursday, October 10th. They issued a “speculative buy” rating and a $1.25 target price for the company.

Milestone Scientific Stock Performance

Shares of MLSS stock opened at $0.81 on Friday. Milestone Scientific has a one year low of $0.52 and a one year high of $1.10. The firm’s 50 day moving average price is $0.91 and its 200-day moving average price is $0.83. The firm has a market cap of $62.87 million, a P/E ratio of -11.63 and a beta of 1.08.

Milestone Scientific (NYSE:MLSS) last released its quarterly earnings results on Thursday, August 15th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The firm had revenue of $1.85 million for the quarter. Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%.

Insider Transactions at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 141,913 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $0.95, for a total value of $134,817.35. Following the sale, the director now owns 4,602,506 shares of the company’s stock, valued at $4,372,380.70. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Over the last 90 days, insiders have sold 251,106 shares of company stock valued at $236,451. 24.75% of the stock is currently owned by company insiders.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.